Technical analysts place Manulife stock price forecast in a consolidation zone between CAD 26.80 and CAD 29.50, expecting a breakout if upcoming earnings outperform analyst expectations. In total, we would have a hard think before deciding on any investment action concerning Manulife Financial. As a result of its low ROE and lack of much reinvestment into the business, the company has seen a disappointing earnings growth rate. Having said that, looking at current analyst estimates, we found that the company's earnings growth rate is expected to see a huge improvement. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Sun Life’s recent earnings painted a more challenging picture. The insurer’s shares dipped by approximately 9% following a quarterly profit that fell short of analysts’ expectations. The Canadian stock’s U.S. segment, which contributes about 20% to its earnings, faced higher claims related to severe medical conditions, particularly in its medical stop-loss insurance. This surge in claims has been partly attributed to delayed medical check-ups during the pandemic, leading to more severe health issues. In response, Sun Life plans to implement a 2% increase in insurance prices to mitigate these challenges. Analysts integrate global insurance demand trends into Manulife stock price forecast, pointing to expanding digital channels that boost customer acquisition efficiency.